Price $1.78 |
Market Cap
73.1M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
-
|
P/S
0.16
|
Dividend %
-
|
|
P/CF
54.4
|
P/FCF
0.9
|
Op. Cash Flow
90.3K
|
FCF
2.0
|
|
Op. Margin
-56.40%
|
Net Margin
-83.60%
|
ROE
-850.10%
|
ROI
-54.70%
|
|
ROA
-48.40%
|
EPS Growth
-
|
Current Ratio
3.9
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Assertio Holdings Inc (ASRT) | $1.35 | - | - | 62.9M | Strong Buy |
| Generex Biotechnology Corporat (GNBT) | $0.08 | - | - | 10.7M | Strong Buy |
| Exicure Inc (XCUR) | $0.42 | - | - | 40.1M | Strong Buy |
| Endo International PLC (ENDP) | $4.99 | - | - | 1.23B | Strong Buy |
| Emmaus Life Sciences Inc (EMMA) | $1.55 | - | - | 71.5M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
